ICR calls for genetic tests of childhood cancers

Experts at flagship cancer centre The Institute of Cancer Research (ICR), and The Royal Marsden NHS Foundation Trust are calling for genetic testing of all childhood cancers.

Understanding the underlying genomic deficiencies which drive cancer can provide information on the likely effectiveness of different treatments, allowing for the most appropriate drug to be used. Dispensing with therapies which are unlikely to be beneficial not only saves money, but allows effective drugs to be used immediately, which in turn mean the tumour does not have time to grow and evolve.

Large scale genomic testing will be dependent on investment in infrastructure, and this call ties into NHS England’s proposed NHS Genomic Medicines Service.

Tagged with

Published on 27. September 2018 in News, News UK